Published in Philos Trans R Soc Lond B Biol Sci on August 29, 2000
Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity. Retrovirology (2004) 1.32
Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation. Oncogene (2005) 1.15
Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia. J Exp Med (2010) 0.98
An antiviral peptide targets a coiled-coil domain of the human T-cell leukemia virus envelope glycoprotein. J Virol (2003) 0.96
The HTLV-1 Virological Synapse. Viruses (2010) 0.88
Regulation of human T-lymphotropic virus type I latency and reactivation by HBZ and Rex. PLoS Pathog (2014) 0.87
Role of resident CNS cell populations in HTLV-1-associated neuroinflammatory disease. Front Biosci (Landmark Ed) (2009) 0.84
Nonhelical leash and alpha-helical structures determine the potency of a peptide antagonist of human T-cell leukemia virus entry. J Virol (2008) 0.82
HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma-A Tale of Two Proteins: Tax and HBZ. Viruses (2016) 0.82
Differential role of PKC-induced c-Jun in HTLV-1 LTR activation by 12-O-tetradecanoylphorbol-13-acetate in different human T-cell lines. PLoS One (2012) 0.76
RNA stability regulates human T cell leukemia virus type 1 gene expression in chronically-infected CD4 T cells. Virology (2017) 0.75
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A (1980) 30.08
Changes in thymic function with age and during the treatment of HIV infection. Nature (1998) 10.27
Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med (1985) 6.46
Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat Med (1999) 4.74
Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today (1991) 3.79
Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest (1988) 3.59
Population dynamics of immune responses to persistent viruses. Science (1996) 3.49
Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol (1998) 3.32
In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol (1990) 2.70
Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol (1996) 2.58
Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc Natl Acad Sci U S A (1989) 2.49
HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A (1999) 2.45
Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood (2000) 1.87
Infectious complications of human T cell leukemia/lymphoma virus type I infection. Clin Infect Dis (1996) 1.73
Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. J Immunol (1999) 1.51
The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J Virol (1994) 1.46
In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology (1993) 1.43
Complex intrapatient sequence variation in the V1 and V2 hypervariable regions of the HIV-1 gp 120 envelope sequence. Virology (1992) 1.27
Immunological studies in tropical spastic paraparesis. Ann Neurol (1990) 1.26
Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax. AIDS Res Hum Retroviruses (1994) 1.19
Clonal expansion of infected cells: a way of life for HTLV-I. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.18
The dynamics of HTLV-I and the CTL response. Immunol Today (1999) 1.14
T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones. Proc Natl Acad Sci U S A (1992) 1.08
Variable immortalizing potential and frequent virus latency in blood-derived T-cell clones infected with human T-cell leukemia virus type I. Blood (1997) 0.91
Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J Neurovirol (1999) 0.91
Spastic paraparesis in a patient carrying defective human T cell leukemia virus type I (HTLV-I) provirus sequences but lacking a humoral or cytotoxic T cell response to HTLV-I. J Infect Dis (1994) 0.87
Evolution in a chronic RNA virus infection: selection on HTLV-I tax protein differs between healthy carriers and patients with tropical spastic paraparesis. J Mol Evol (1996) 0.87
Effect of human serum anti-HTLV antibodies on viral antigen induction in vitro cultured peripheral lymphocytes from adult T-cell leukemia patients and healthy virus carriers. Int J Cancer (1985) 0.87
Factors affecting the natural history of human immunodeficiency virus infection. Immunodefic Rev (1988) 0.86
Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load. J Neurol Sci (1992) 0.84
In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis. Am J Trop Med Hyg (1995) 0.83
Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature (1991) 10.85
Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci U S A (1997) 8.05
Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature (1995) 3.61
Population dynamics of immune responses to persistent viruses. Science (1996) 3.49
Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol (1998) 3.32
Aseptic meningitis and encephalitis: the role of PCR in the diagnostic laboratory. J Clin Microbiol (1997) 2.76
Diagnosis of viral infections of the central nervous system: clinical interpretation of PCR results. Lancet (1997) 2.50
HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A (1999) 2.45
Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission. HIV Med (2001) 2.33
Selection forces and constraints on retroviral sequence variation. Science (2001) 2.17
Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants. J Immunol (1986) 2.13
Increased incidence of CPR-related rib fractures in infants--is it related to changes in CPR technique? Resuscitation (2011) 2.03
Pre-eclampsia, antiretroviral therapy, and immune reconstitution. Lancet (2002) 1.95
Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology (1992) 1.94
Cytotoxic T-cell response to respiratory syncytial virus in mice. J Virol (1985) 1.92
Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood (2000) 1.87
Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet (1987) 1.80
The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol (2000) 1.73
Definition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection. Microbiol Immunol (1992) 1.69
Long-term persistence of activated cytotoxic T lymphocytes after viral infection of the central nervous system. J Exp Med (1998) 1.68
Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol (1998) 1.65
Comparative risks and costs of male and female sterilization. Am J Public Health (1985) 1.65
The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis. J Virol (1994) 1.46
Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity (2000) 1.34
Do infectious diseases drive MHC diversity? Microbes Infect (2000) 1.26
Cycles, chaos, and evolution in virus cultures: a model of defective interfering particles. Proc Natl Acad Sci U S A (1994) 1.24
The immunogenicity of intracerebral virus infection depends on anatomical site. J Virol (1997) 1.19
Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1. Proc Biol Sci (2001) 1.19
Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax. J Virol (1995) 1.15
HTLV-I/II associated disease in England and Wales, 1993-7: retrospective review of serology requests. BMJ (2000) 1.15
High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis. Virology (1996) 1.14
The dynamics of HTLV-I and the CTL response. Immunol Today (1999) 1.14
No evidence of antibody to human foamy virus in widespread human populations. AIDS Res Hum Retroviruses (1996) 1.13
Sudden, unexpected, natural death in childhood. Pediatr Pathol (1990) 1.12
Both wild-type and strongly attenuated bovine leukemia viruses protect peripheral blood mononuclear cells from apoptosis. J Virol (1997) 1.11
Prospective study of HTLV-I infection in an initially asymptomatic cohort. J Acquir Immune Defic Syndr (1999) 1.09
High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells. Blood (2001) 1.09
Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus. Proc Natl Acad Sci U S A (1986) 1.09
Clinical outcomes of acute myocarditis in childhood. Heart (1999) 1.07
Clinical implications of stopping nevirapine-based antiretroviral therapy: relative pharmacokinetics and avoidance of drug resistance. HIV Med (2004) 1.06
Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells. J Infect Dis (1994) 1.06
Increased level of arginase activity correlates with disease severity in HIV-seropositive patients. J Infect Dis (2010) 1.05
Renal-cell carcinoma in children: a different disorder from its adult counterpart? Med Pediatr Oncol (1998) 1.04
Pooling of samples for seroepidemiological surveillance of human T-cell lymphotropic virus types I and II. Virus Res (2001) 1.04
Restrictive dermopathy: a newly recognized autosomal recessive skin dysplasia. Am J Med Genet (1986) 1.00
Is first trimester exposure to the combination of antiretroviral therapy and folate antagonists a risk factor for congenital abnormalities? Sex Transm Infect (2001) 0.99
Prognostic factors in the treatment of lymphatic malformations. Arch Otolaryngol Head Neck Surg (1997) 0.99
RT-PCR without RNA isolation. Biotechniques (1996) 0.98
Protection against lethal influenza virus encephalitis by intranasally primed CD8+ memory T cells. J Immunol (1996) 0.97
Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients. Br J Haematol (2001) 0.97
Pattern of cardiac malformation in oculoauriculovertebral spectrum. Am J Med Genet (1993) 0.96
High frequency of viral protein expression in human T cell lymphotropic virus type 1-infected peripheral blood mononuclear cells. AIDS Res Hum Retroviruses (2000) 0.96
Search for the rare leptonic decay B--->tau-nutau. Phys Rev Lett (2005) 0.96
Rhabdomyosarcoma arising within congenital pulmonary cysts: report of three cases. J Pediatr Surg (1992) 0.95
Selection of cytotoxicity markers for the screening of new chemical entities in a pharmaceutical context: a preliminary study using a multiplexing approach. Toxicol In Vitro (2008) 0.95
Virus dissemination through the brain parenchyma without immunologic control. J Immunol (1997) 0.94
Quantification of proviral DNA load in human T-cell leukaemia virus type I infections. J Virol Methods (1998) 0.94
Giant hydatid lung cysts in the Canadian northwest: outcome of conservative treatment in three children. J Pediatr Surg (1993) 0.93
Murine cytotoxic T cells specific to respiratory syncytial virus recognize different antigenic subtypes of the virus. J Gen Virol (1986) 0.92
Bovine herpesvirus type 1 glycoprotein H is essential for penetration and propagation in cell culture. J Gen Virol (1998) 0.91
Analysis of substrate cleavage by recombinant protease of human T cell leukaemia virus type 1 reveals preferences and specificity of binding. J Gen Virol (1994) 0.91
Do T cells cause HTLV-1-associated disease?: a taxing problem. Clin Exp Immunol (1994) 0.90
Improved oral bioavailability of lopinavir in melt-extruded tablet formulation reduces impact of third trimester on lopinavir plasma concentrations. Antimicrob Agents Chemother (2011) 0.90
Cardiac manifestations of congenital fiber-type disproportion myopathy. J Child Neurol (1999) 0.89
Evolutionary dynamics of HTLV-I. J Mol Evol (2000) 0.88
Spastic paraparesis in a patient carrying defective human T cell leukemia virus type I (HTLV-I) provirus sequences but lacking a humoral or cytotoxic T cell response to HTLV-I. J Infect Dis (1994) 0.87
Evolution in a chronic RNA virus infection: selection on HTLV-I tax protein differs between healthy carriers and patients with tropical spastic paraparesis. J Mol Evol (1996) 0.87
Passively acquired antibodies to respiratory syncytial virus impair the secondary cytotoxic T-cell response in the neonatal mouse. Immunology (1986) 0.87
The effect of implantation of aortic stents on compliance and blood flow. An experimental study in pigs. Cardiol Young (2001) 0.87
Recognition of respiratory syncytial virus fusion protein by mouse cytotoxic T cell clones and a human cytotoxic T cell line. J Gen Virol (1989) 0.87
Inflammatory pseudotumor of the uterus. Int J Gynecol Pathol (1987) 0.87
Pulmonary vascular disease in neonates with transposition of the great arteries and intact ventricular septum. Br Heart J (1993) 0.86
Undifferentiated (embryonal) sarcoma of the liver: ultrastructural and immunohistochemical similarities with malignant fibrous histiocytoma. Hum Pathol (1985) 0.86
Review of uptake of interventions to reduce mother to child transmission of HIV by women aware of their HIV status. BMJ (1998) 0.86
The role of cytotoxic T lymphocytes in human T-cell lymphotropic virus type 1 infection. J Theor Biol (2000) 0.86
Human immunodeficiency virus variants that escape cytotoxic T-cell recognition. AIDS Res Hum Retroviruses (1992) 0.86
Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission. HIV Med (2013) 0.86
Infant HIV infection despite "universal" antenatal testing. Arch Dis Child (2007) 0.85
Cardiac abnormalities and nonimmune hydrops fetalis: a coincidental, not causal, relationship. Pediatr Pathol (1989) 0.85
Severe bleeding disorders in children with normal coagulation screening tests. Br Med J (Clin Res Ed) (1982) 0.85
Human T cell leukaemia/lymphoma virus infection in pregnant women in the United Kingdom: population study. BMJ (2000) 0.84
Intradermal DNA immunization of mice against influenza A virus using the novel PowderJect system. Vaccine (1998) 0.83
Measurement of the CP asymmetry amplitude sin2beta with B0 mesons. Phys Rev Lett (2002) 0.83
Cardiomyopathy associated with nonendemic selenium deficiency in a Caucasian adolescent. Am J Clin Nutr (1990) 0.83
In vivo selection of T-cell receptor junctional region sequences by HLA-A2 human T-cell lymphotropic virus type 1 Tax11-19 peptide complexes. J Virol (2001) 0.83
Chimeric matrix proteins encoded by defective proviruses with large internal deletions in human T-cell leukemia virus type 1-infected humans. J Virol (2000) 0.82
Use of PCR and immunofluorescence to detect bovine herpesvirus 1 recombinants. J Virol Methods (2001) 0.82
The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'? J Antimicrob Chemother (2009) 0.82
Safety of nevirapine in pregnancy. HIV Med (2007) 0.82